Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: South Korea Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20134
20141
20171
20193
20213
20221
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8
Recruiting5
Completed4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines5
Loxo Oncology, Inc.4
Acerta Pharma BV2
Gilead Sciences2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
AbbVie1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell19
Lymphoma, Non-Hodgkin5
Hematologic Diseases4
Lymphoma, B-Cell4
Lymphoma, Follicular3
Waldenstrom Macroglobulinemia3
Leukemia, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Bronchiolitis Obliterans Syndrome1
Leukemia1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.